跳至主要内容
临床试验/NCT01789333
NCT01789333撤回不适用

Study of the Safety and Effectiveness of Photochemically Induced Collagen Cross- Linking at Higher Irradiances in Patients With Keratoconus or Ectasia

Stephen Trokel1 个研究点 分布在 1 个国家开始时间: 2010年9月1日最近更新:
适应症
干预措施
相关药物

试验速览

阶段
不适用
状态
撤回
发起方
试验地点
1
主要终点
Change in Total Optical Aberrations of the Cornea following Cross-Linking

研究概览

简要总结

The purpose of the study is to see if brighter lights will allow for shortening of the treatment time required to stabilize the eyes of patients with keratoconus or a bulging cornea. The investigators will be comparing the therapeutic effects of two different higher brightnesses of ultra violet light on a riboflavin treated eye. One light will be twice as bright as the other and the exposure time of these brighter lights to deliver equivalent energy to the cornea will be reduced from the standard 30 minutes to 10 and 5 minutes. Riboflavin is vitamin B2 and the investigators are trying to determine if an identical clinical effect can be achieved the brighter treatment lights are used for shorter times. The investigators will also monitor the clinical effect and the status of the cornea to see if additional risks are associated with the brighter light.

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Treatment
盲法
None

入排标准

年龄范围
16 Years 至 —(Child, Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Subjects who have one or both eyes that meet two of the following criteria will be considered candidates for this study:
  • 16 years of age or older
  • Having a diagnosis of progressive keratoconus or pellucid marginal degeneration.
  • Characteristic pattern of deformity as analyzed by the Pentacam map.
  • Minimal thickness of 350 microns
  • The ability to sign a written informed consent
  • States a willingness and ability to comply with schedule for follow-up visits
  • Subject willing to remove contact lenses prior to evaluation and treatment
  • Inclusion criteria for ectasia
  • History of having undergone a keratorefractive procedure and show:
  • Steepening by Pentacam study
  • Thinning of cornea
  • Shift in the position of thinnest portion of cornea
  • Unstable refraction with increasing myopia and astigmatism
  • Development of irregular astigmatism
  • At least two of the above criteria must be present.

排除标准

  • Subjects meeting any of the following criteria will be excluded from this study:
  • Subjects meeting any of the following criteria will be excluded from this protocol:
  • Eyes classified as either normal or atypical normal,
  • Corneal pachymetry ≤ 350 microns at the thinnest point in treatment zone measured by Pentacam.
  • A history of delayed epithelial healing.
  • Pregnancy (including plan to become pregnant) or lactation during the course of the study
  • A known sensitivity to study medications
  • Patients with nystagmus or any other condition that is severe enough to prevent steady gaze during the treatment
  • Inability to cooperate with diagnostic tests.
  • Patients with a current condition that, in the investigator's opinion, would interfere with or prolong epithelial healing.
  • Patients who are unable to remain supine and tolerate a lid speculum.

研究组 & 干预措施

9 mw/cm2 at 10 minutes group

Experimental

30 patients will be treated with UVA light source at 9 mw/cm2 at 10 minutes. Drug: Riboflavin Dose:1 drop every 2 to 3 minutes for 15 to 20 minutes

干预措施: UVA Light with irradiance exposure of 9 mW/cm2 (Device)

9 mw/cm2 at 10 minutes group

Experimental

30 patients will be treated with UVA light source at 9 mw/cm2 at 10 minutes. Drug: Riboflavin Dose:1 drop every 2 to 3 minutes for 15 to 20 minutes

干预措施: Riboflavin 0.1% ophthalmic solution (Drug)

结局指标

主要结局

Change in Total Optical Aberrations of the Cornea following Cross-Linking

时间窗: Baseline to 6 months

Assessment of changes in corneal curvature, as analyzed using a Pentacam Scheimpflug Analyzer will be used in all patients. This allows measurement of corneal thickness, maximum and minimum curvatures and aberration analysis of the cornea as an optical element. The most significant objective measure of change is the total Higher Order Aberrations of the cornea and the Kmax, or steepest curvature of the cornea. Analysis of corneal curvature is directly related to improvement in the corneal shape which is directly related to visual function.

次要结局

未报告次要终点

研究者

发起方
Stephen Trokel
申办方类型
Other
责任方
Sponsor Investigator
主要研究者

Stephen Trokel

Professor of Clinical Ophthalmology

Columbia University

研究点 (1)

Loading locations...

相似试验

Higher Irradiance in Keratoconus Ectasia | 临床试验